LTX-109 gel, 3% w/w

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Nasal Decolonization of Staphylococcus Aureus

Drug Information

Target Indication

Nasal Decolonization of Staphylococcus Aureus

Clinical Trial

Last updated: 7/31/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

PHM.MC

PharmaMar, S.A.

Related Pipeline

NASH - Nonalcoholic Steatohepatitis

Generalized Adult Periodontitis

Perennial Allergic Rhinitis

Schizophrenia

Asthma

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts